首页 > 最新文献

Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery最新文献

英文 中文
GASTRIC NEUROENDOCRINE TUMOR: WHEN SURGICAL TREATMENT IS INDICATED? 胃神经内分泌肿瘤:何时需要手术治疗?
Pub Date : 2023-10-13 eCollection Date: 2023-01-01 DOI: 10.1590/0102-672020230050e1768
Ademar Caetano Assis Filho, Valdir Tercioti Junior, Nelson Adami Andreollo, José Antonio Possatto Ferrer, João de Souza Coelho Neto, Luiz Roberto Lopes

Background: Gastric neuroendocrine tumors are a heterogeneous group of neoplasms that produce bioactive substances. Their treatment varies according to staging and classification, using endoscopic techniques, open surgery, chemotherapy, radiotherapy, and drugs analogous to somatostatin.

Aims: To identify and review cases of gastric neuroendocrine neoplasia submitted to surgical treatment.

Methods: Review of surgically treated patients from 1983 to 2018.

Results: Fifteen patients were included, predominantly female (73.33%), with a mean age of 55.93 years. The most common symptom was epigastric pain (93.3%), and the mean time of symptom onset was 10.07 months. The preoperative upper digestive endoscopy (UDE) indicated a predominance of cases with 0 to 1 lesion (60%), sizing ≥1.5 cm (40%), located in the gastric antrum (53.33%), with ulceration (60%), and Borrmann III (33.33%) classification. The assessment of the surgical specimen indicated a predominance of invasive neuroendocrine tumors (60%), with angiolymphatic invasion in most cases (80%). Immunohistochemistry for chromogranin A was positive in 60% of cases and for synaptophysin in 66.7%, with a predominant Ki-67 index between 0 and 2%. Metastasis was observed in 20% of patients. The surgical procedure most performed was subtotal gastrectomy with Roux-en-Y reconstruction (53.3%). Tumor recurrence occurred in 20% of cases and a new treatment was required in 26.67%.

Conclusions: Gastric neuroendocrine tumors have a low incidence in the general population, and surgical treatment is indicated for advanced lesions. The study of its management gains importance in view of the specificities of each case and the need for adequate conduct to prevent recurrences and complications.

背景:胃神经内分泌肿瘤是一组产生生物活性物质的异质性肿瘤。根据分期和分类,他们的治疗方法各不相同,包括内镜技术、开放手术、化疗、放疗和类似生长抑素的药物。目的:鉴定和回顾接受手术治疗的胃神经内分泌肿瘤病例。方法:回顾1983年至2018年接受手术治疗的患者。结果:纳入15名患者,主要为女性(73.33%),平均年龄55.93岁。最常见的症状是上腹痛(93.3%),症状出现的平均时间为10.07个月。术前上消化道内窥镜检查(UDE)显示,大多数病例有0至1个病变(60%),大小≥1.5厘米(40%),位于胃窦(53.33%),溃疡(60%)和Borrmann III(33.33%)分类。对手术标本的评估表明,侵袭性神经内分泌肿瘤占主导地位(60%),在大多数情况下血管淋巴浸润(80%)。60%的病例中嗜铬粒蛋白A的免疫组织化学阳性,66.7%的病例中突触素阳性,Ki-67指数在0至2%之间。20%的患者出现转移。最常见的外科手术是胃大部切除Roux-en-Y重建术(53.3%)。20%的病例发生肿瘤复发,26.67%的病例需要新的治疗。结论:胃神经内分泌肿瘤在普通人群中发病率较低,晚期病变需要手术治疗。鉴于每个病例的特殊性以及需要进行适当的行为以防止复发和并发症,对其管理的研究变得越来越重要。
{"title":"GASTRIC NEUROENDOCRINE TUMOR: WHEN SURGICAL TREATMENT IS INDICATED?","authors":"Ademar Caetano Assis Filho,&nbsp;Valdir Tercioti Junior,&nbsp;Nelson Adami Andreollo,&nbsp;José Antonio Possatto Ferrer,&nbsp;João de Souza Coelho Neto,&nbsp;Luiz Roberto Lopes","doi":"10.1590/0102-672020230050e1768","DOIUrl":"10.1590/0102-672020230050e1768","url":null,"abstract":"<p><strong>Background: </strong>Gastric neuroendocrine tumors are a heterogeneous group of neoplasms that produce bioactive substances. Their treatment varies according to staging and classification, using endoscopic techniques, open surgery, chemotherapy, radiotherapy, and drugs analogous to somatostatin.</p><p><strong>Aims: </strong>To identify and review cases of gastric neuroendocrine neoplasia submitted to surgical treatment.</p><p><strong>Methods: </strong>Review of surgically treated patients from 1983 to 2018.</p><p><strong>Results: </strong>Fifteen patients were included, predominantly female (73.33%), with a mean age of 55.93 years. The most common symptom was epigastric pain (93.3%), and the mean time of symptom onset was 10.07 months. The preoperative upper digestive endoscopy (UDE) indicated a predominance of cases with 0 to 1 lesion (60%), sizing ≥1.5 cm (40%), located in the gastric antrum (53.33%), with ulceration (60%), and Borrmann III (33.33%) classification. The assessment of the surgical specimen indicated a predominance of invasive neuroendocrine tumors (60%), with angiolymphatic invasion in most cases (80%). Immunohistochemistry for chromogranin A was positive in 60% of cases and for synaptophysin in 66.7%, with a predominant Ki-67 index between 0 and 2%. Metastasis was observed in 20% of patients. The surgical procedure most performed was subtotal gastrectomy with Roux-en-Y reconstruction (53.3%). Tumor recurrence occurred in 20% of cases and a new treatment was required in 26.67%.</p><p><strong>Conclusions: </strong>Gastric neuroendocrine tumors have a low incidence in the general population, and surgical treatment is indicated for advanced lesions. The study of its management gains importance in view of the specificities of each case and the need for adequate conduct to prevent recurrences and complications.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"36 ","pages":"e1768"},"PeriodicalIF":0.0,"publicationDate":"2023-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578147/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49685586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LIVER TRANSPLANTATION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTRIC STUDY. 原发性硬化性胆管炎患者的肝移植:一项多中心研究。
Pub Date : 2023-10-13 eCollection Date: 2023-01-01 DOI: 10.1590/0102-672020230051e1769
Henrique de Aguiar Wiederkehr, Julio Cesar Wiederkehr, Mauro Rafael Da Igreja, Eduardo Brommelstroet Ramos, Marcelo Scheidemantel Nogara, Debora Stroparo Soffiatti, Andrew Massutti, Vivian Laís Sasaki, Barbara de Aguiar Wiederkehr, Igor Raphael Mathias Valejo, Júlio Cezar Uili Coelho

Background: The prevalence of primary sclerosing cholangitis (PSC) in the general population has not yet been clearly established. The management of PSC should focus on delaying the progression of the disease and restraining its complications. The only curative therapy for the disease remains liver transplantation (LT). PSC is currently the fifth most common indication for LT and corresponds to 5% of all LT indications in adults.

Aims: Our objective is to evaluate the indications and outcomes of PSC patients undergoing LT in three liver transplantation centers in southern Brazil - Hospital Santa Isabel in Blumenau, Santa Catarina state, and Hospital das Clínicas and Hospital Nossa Senhora das Graças, in Curitiba, Parana state).

Methods: This is a longitudinal observational study of patients with PSC who underwent LT in three major Brazilian medical centers. Electronic medical records and study protocols of all patients subjected to LT from January 2011 to December 2021 were retrospectively reviewed.

Results: Of the 1,362 transplants performed in the three medical centers, 37 were due to PSC. Recurrence of PSC occurred in three patients (8.1%) in 3.0±2.4 years (range, 1-4 years). The 1-year and 5-year survival rates after the first LT were 83.8 and 80.6%, respectively. The 1-year and 5-year graft survival rates were, respectively, 83.8 and 74.8%.

Conclusions: Our experience with LT in patients with PSC demonstrated good patient and graft survival results. Most deaths were due to common factors in patients undergoing LT.

背景:原发性硬化性胆管炎(PSC)在普通人群中的患病率尚未明确确定。PSC的管理应侧重于延缓疾病进展和抑制其并发症。这种疾病的唯一治疗方法仍然是肝移植。PSC是目前LT第五常见的适应症,相当于成人所有LT适应症的5%。目的:我们的目标是评估在巴西南部三个肝移植中心接受LT的PSC患者的适应症和结果,这三个中心分别是位于圣卡塔琳娜州布鲁门瑙的Santa Isabel医院和位于库里蒂巴的Clínicas医院和Nossa Senhora das Graças医院,方法:这是一项对在巴西三个主要医疗中心接受LT的PSC患者的纵向观察研究。对2011年1月至2021年12月接受LT的所有患者的电子病历和研究方案进行了回顾性审查。结果:在三个医疗中心进行的1362例移植中,37例是PSC。PSC在3.0±2.4年(范围1-4年)内复发3例(8.1%)。首次LT后的1年和5年生存率分别为83.8%和80.6%。1年和5年移植物存活率分别为83.8%和74.8%。结论:我们对PSC患者进行LT的经验表明,患者和移植物的存活率良好。大多数死亡是由LT患者的常见因素引起的。
{"title":"LIVER TRANSPLANTATION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTRIC STUDY.","authors":"Henrique de Aguiar Wiederkehr,&nbsp;Julio Cesar Wiederkehr,&nbsp;Mauro Rafael Da Igreja,&nbsp;Eduardo Brommelstroet Ramos,&nbsp;Marcelo Scheidemantel Nogara,&nbsp;Debora Stroparo Soffiatti,&nbsp;Andrew Massutti,&nbsp;Vivian Laís Sasaki,&nbsp;Barbara de Aguiar Wiederkehr,&nbsp;Igor Raphael Mathias Valejo,&nbsp;Júlio Cezar Uili Coelho","doi":"10.1590/0102-672020230051e1769","DOIUrl":"10.1590/0102-672020230051e1769","url":null,"abstract":"<p><strong>Background: </strong>The prevalence of primary sclerosing cholangitis (PSC) in the general population has not yet been clearly established. The management of PSC should focus on delaying the progression of the disease and restraining its complications. The only curative therapy for the disease remains liver transplantation (LT). PSC is currently the fifth most common indication for LT and corresponds to 5% of all LT indications in adults.</p><p><strong>Aims: </strong>Our objective is to evaluate the indications and outcomes of PSC patients undergoing LT in three liver transplantation centers in southern Brazil - Hospital Santa Isabel in Blumenau, Santa Catarina state, and Hospital das Clínicas and Hospital Nossa Senhora das Graças, in Curitiba, Parana state).</p><p><strong>Methods: </strong>This is a longitudinal observational study of patients with PSC who underwent LT in three major Brazilian medical centers. Electronic medical records and study protocols of all patients subjected to LT from January 2011 to December 2021 were retrospectively reviewed.</p><p><strong>Results: </strong>Of the 1,362 transplants performed in the three medical centers, 37 were due to PSC. Recurrence of PSC occurred in three patients (8.1%) in 3.0±2.4 years (range, 1-4 years). The 1-year and 5-year survival rates after the first LT were 83.8 and 80.6%, respectively. The 1-year and 5-year graft survival rates were, respectively, 83.8 and 74.8%.</p><p><strong>Conclusions: </strong>Our experience with LT in patients with PSC demonstrated good patient and graft survival results. Most deaths were due to common factors in patients undergoing LT.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"36 ","pages":"e1769"},"PeriodicalIF":0.0,"publicationDate":"2023-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578153/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49685587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ONLAY VERSUS RIVES-STOPPA TECHNIQUES IN THE TREATMENT OF INCISIONAL HERNIAS. 昂莱与缝塞技术治疗切口疝。
Pub Date : 2023-10-13 eCollection Date: 2023-01-01 DOI: 10.1590/0102-672020230048e1766
Alana Kezya Pereira-Rodrigues, João Victor Santos Maceio-Da-Graça, Erik Matheus Lemos de Oliveira Ferreira, Claudio Claudino Alves-Almeida

Background: In the surgical correction of large incisional hernias, the use of a prosthesis is essential in most cases regardless of the technique chosen. The preference is for the polypropylene prosthesis.

Aims: To compare the onlay and Rives-Stoppa techniques in the correction of incisional hernias, their immediate results, complications, advantages, and disadvantages.

Methods: Two groups of patients with incisional hernias were analyzed, submitted to the onlay (19 patients) and Rives-Stoppa (17 patients) techniques, and that used polypropylene prostheses. General epidemiological variables, perioperative data variables, and postoperative complications were assessed.

Results: The patients' epidemiologic profile was similar between both groups. The majority were women (58.4%), with a mean age of 65.5 years and a previous mean body mass index of 41.5 kg/m². The Rives-Stoppa technique was employed in most patients (52.7%). Those submitted to the onlay technique had longer abdominal drainage time and longer hospital stay, as well as a higher incidence of seromas and surgical wound infection.

Conclusions: The incisional herniorrhaphy technique with the placement of a pre-peritoneal polypropylene mesh by the Rives-Stoppa technique was superior to the onlay due to lower rates of drain use, hospital stay, and postoperative complications.

背景:在大切口疝的外科矫正中,无论选择何种技术,在大多数情况下,使用假体都是必不可少的。首选聚丙烯假体。目的:比较昂莱和Rives-Stoppa技术在切口疝矫正中的疗效、并发症、优缺点。方法:对两组切口疝患者进行分析,采用onlay(19例)和Rives Stoppa(17例)技术,并使用聚丙烯假体。评估一般流行病学变量、围手术期数据变量和术后并发症。结果:两组患者的流行病学特征相似。大多数是女性(58.4%),平均年龄65.5岁,以前的平均体重指数为41.5 kg/m²。大多数患者(52.7%)采用Rives-Stoppa技术。接受onlay技术的患者腹部引流时间更长,住院时间更长,血清瘤和手术伤口感染的发生率更高。结论:Rives-Stoppa腹膜前聚丙烯网片切口疝修补术由于引流管使用率、住院时间和术后并发症较低,优于在线疝修补术。
{"title":"ONLAY VERSUS RIVES-STOPPA TECHNIQUES IN THE TREATMENT OF INCISIONAL HERNIAS.","authors":"Alana Kezya Pereira-Rodrigues,&nbsp;João Victor Santos Maceio-Da-Graça,&nbsp;Erik Matheus Lemos de Oliveira Ferreira,&nbsp;Claudio Claudino Alves-Almeida","doi":"10.1590/0102-672020230048e1766","DOIUrl":"10.1590/0102-672020230048e1766","url":null,"abstract":"<p><strong>Background: </strong>In the surgical correction of large incisional hernias, the use of a prosthesis is essential in most cases regardless of the technique chosen. The preference is for the polypropylene prosthesis.</p><p><strong>Aims: </strong>To compare the onlay and Rives-Stoppa techniques in the correction of incisional hernias, their immediate results, complications, advantages, and disadvantages.</p><p><strong>Methods: </strong>Two groups of patients with incisional hernias were analyzed, submitted to the onlay (19 patients) and Rives-Stoppa (17 patients) techniques, and that used polypropylene prostheses. General epidemiological variables, perioperative data variables, and postoperative complications were assessed.</p><p><strong>Results: </strong>The patients' epidemiologic profile was similar between both groups. The majority were women (58.4%), with a mean age of 65.5 years and a previous mean body mass index of 41.5 kg/m². The Rives-Stoppa technique was employed in most patients (52.7%). Those submitted to the onlay technique had longer abdominal drainage time and longer hospital stay, as well as a higher incidence of seromas and surgical wound infection.</p><p><strong>Conclusions: </strong>The incisional herniorrhaphy technique with the placement of a pre-peritoneal polypropylene mesh by the Rives-Stoppa technique was superior to the onlay due to lower rates of drain use, hospital stay, and postoperative complications.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"36 ","pages":"e1766"},"PeriodicalIF":0.0,"publicationDate":"2023-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578152/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49685588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
VALIDITY OF THE BRAZILIAN-PORTUGUESE VERSION OF MOOREHEAD-ARDELT QUALITY OF LIFE QUESTIONNAIRE II AMONG PATIENTS WITH SEVERE OBESITY. MOOREHEAD-ARDELT生活质量问卷II在严重肥胖患者中的有效性。
Pub Date : 2023-10-13 eCollection Date: 2023-01-01 DOI: 10.1590/0102-672020230049e1767
Mariane de Carvalho Cremonesi, Leorides Duarte-Guerra, Denis Pajecki, Marco Aurelio Santo, Francisco Lotufo Neto, Yuan-Pang Wang

Background: Patients with obesity present multiple comorbid psychiatric conditions and experience impairments in health-related quality of life. Reliable and valid tools that evaluate health-related quality of life are essential for clinical practice.

Aims: This study aimed to investigate the reliability and validity of the six-item Moorehead-Ardelt Quality of Life Questionnaire II among Brazilian patients with severe obesity.

Methods: We assessed 387 patients (mean age 43 years, 78.8% women, mean body mass index of 46.5 kg/m²) on the waiting list of a bariatric surgery center. Trained research assistants concurrently applied the Moorehead-Ardelt Quality of Life-II, the Montgomery-Åsberg Depression Rating Scale, and the Global Assessment of Functioning for assessing health-related quality of life, comorbid depressive symptoms, and patient functioning level, respectively.

Results: The internal consistency of the Moorehead-Ardelt Quality of Life-II was considered acceptable. The total score was correlated with the severity of depressive symptoms and functioning level. The more body mass index increases, the more health-related quality of life worsens. The Moorehead-Ardelt Quality of Life-II presented a unidimensional structure.

Conclusions: The unidimensional Moorehead-Ardelt Quality of Life-II is a reliable and valid measure for evaluating health-related quality of life in Brazilian patients with severe obesity. The questionnaire allows to quickly assess the health-related quality of life of patients in different bariatric contexts, considering depression and functional level.

背景:肥胖患者存在多种共病精神疾病,并在健康相关的生活质量方面存在障碍。评估健康相关生活质量的可靠有效工具对临床实践至关重要。目的:本研究旨在调查Moorehead Ardelt生活质量问卷II在巴西重度肥胖患者中的六项信度和有效性。方法:我们评估了387名在减肥手术中心等待名单上的患者(平均年龄43岁,女性78.8%,平均体重指数46.5 kg/m²)。受过培训的研究助理同时应用Moorehead Ardelt生活质量II、Montgomery-Åsberg抑郁评定量表和全球功能评估,分别评估健康相关的生活质量、共病抑郁症状和患者功能水平。结果:Moorehead Ardelt生活质量II的内部一致性被认为是可接受的。总分与抑郁症状的严重程度和功能水平相关。体重指数增加得越多,与健康相关的生活质量就越差。Moorehead Ardelt的《生活质量II》呈现了一种一维结构。结论:一维Moorehead-Ardelt生活质量II是评估巴西重度肥胖患者健康相关生活质量的可靠有效指标。该问卷可以考虑抑郁和功能水平,快速评估不同减肥背景下患者的健康相关生活质量。
{"title":"VALIDITY OF THE BRAZILIAN-PORTUGUESE VERSION OF MOOREHEAD-ARDELT QUALITY OF LIFE QUESTIONNAIRE II AMONG PATIENTS WITH SEVERE OBESITY.","authors":"Mariane de Carvalho Cremonesi,&nbsp;Leorides Duarte-Guerra,&nbsp;Denis Pajecki,&nbsp;Marco Aurelio Santo,&nbsp;Francisco Lotufo Neto,&nbsp;Yuan-Pang Wang","doi":"10.1590/0102-672020230049e1767","DOIUrl":"10.1590/0102-672020230049e1767","url":null,"abstract":"<p><strong>Background: </strong>Patients with obesity present multiple comorbid psychiatric conditions and experience impairments in health-related quality of life. Reliable and valid tools that evaluate health-related quality of life are essential for clinical practice.</p><p><strong>Aims: </strong>This study aimed to investigate the reliability and validity of the six-item Moorehead-Ardelt Quality of Life Questionnaire II among Brazilian patients with severe obesity.</p><p><strong>Methods: </strong>We assessed 387 patients (mean age 43 years, 78.8% women, mean body mass index of 46.5 kg/m²) on the waiting list of a bariatric surgery center. Trained research assistants concurrently applied the Moorehead-Ardelt Quality of Life-II, the Montgomery-Åsberg Depression Rating Scale, and the Global Assessment of Functioning for assessing health-related quality of life, comorbid depressive symptoms, and patient functioning level, respectively.</p><p><strong>Results: </strong>The internal consistency of the Moorehead-Ardelt Quality of Life-II was considered acceptable. The total score was correlated with the severity of depressive symptoms and functioning level. The more body mass index increases, the more health-related quality of life worsens. The Moorehead-Ardelt Quality of Life-II presented a unidimensional structure.</p><p><strong>Conclusions: </strong>The unidimensional Moorehead-Ardelt Quality of Life-II is a reliable and valid measure for evaluating health-related quality of life in Brazilian patients with severe obesity. The questionnaire allows to quickly assess the health-related quality of life of patients in different bariatric contexts, considering depression and functional level.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"36 ","pages":"e1767"},"PeriodicalIF":0.0,"publicationDate":"2023-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578149/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49685591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
THE LANGUAGE MODELS IN HEALTHCARE AND THE ROLE OF CHATGPT: COMMENTS 医疗保健中的语言模型与CHATGPT的作用
Pub Date : 2023-09-15 eCollection Date: 2023-01-01 DOI: 10.1590/0102-672020230043e1761
Amnuay Kleebayoon, Viroj Wiwanitkit

The introduction of chatbots has been one of the most intriguing advances in artificial intelligence. There are numerous potential uses for artificial intelligence in clinical research. However, there are also some issues that require attention. Everyone agrees that AI requires a more stable foundation and that a cutting-edge approach is necessary for AI to operate effectively.

聊天机器人的引入是人工智能领域最有趣的进步之一。人工智能在临床研究中有许多潜在用途。然而,也有一些问题需要注意。每个人都同意,人工智能需要一个更稳定的基础,而尖端的方法对于人工智能的有效运行是必要的。
{"title":"THE LANGUAGE MODELS IN HEALTHCARE AND THE ROLE OF CHATGPT: COMMENTS","authors":"Amnuay Kleebayoon,&nbsp;Viroj Wiwanitkit","doi":"10.1590/0102-672020230043e1761","DOIUrl":"https://doi.org/10.1590/0102-672020230043e1761","url":null,"abstract":"<p><p>The introduction of chatbots has been one of the most intriguing advances in artificial intelligence. There are numerous potential uses for artificial intelligence in clinical research. However, there are also some issues that require attention. Everyone agrees that AI requires a more stable foundation and that a cutting-edge approach is necessary for AI to operate effectively.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"36 ","pages":"e1761"},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510369/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41157276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DIAGNOSIS OF ACUTE APPENDICITIS AND APPENDICULAR PERFORATION: EVALUATION OF PLATELET INDICES AND RED CELL DISTRIBUTION WIDTH AS EMERGING BIOMARKERS. 急性阑尾炎和阑尾穿孔的诊断:血小板指数和红细胞分布宽度作为新兴生物标志物的评估。
Pub Date : 2023-09-15 eCollection Date: 2023-01-01 DOI: 10.1590/0102-672020230039e1757
Chetan Ag, Vijaya Patil

Background: Acute appendicitis is a common surgical emergency worldwide. Recent studies on hematological inflammatory markers concerning acute appendicitis have shown variable results.

Aims: The aim of this study was to evaluate pre-operative values of platelet indices such as mean platelet volume (MPV) and platelet distribution width (PDW), and red cell distribution width (RDW) in relation to the diagnosis of acute appendicitis and their efficacy as predictors of appendicular perforation.

Methods: A prospective observational study of 190 patients diagnosed with appendicitis and who underwent an appendectomy was undertaken and confirmed histopathologically. Preoperatively, blood samples of white blood cells (WBCs), platelet count, MPV, PDW, and RDW were analyzed using a Sysmex XN1000 analyzer machine.

Results: Of 190 patients, 169 had acute appendicitis, and 21 had perforated appendicitis. The mean age of patients was 28.04 ± 14.2 years. The male-to-female ratio was 1.5:1. The WBC (p<0.05), MPV (p<0.05), and PDW (p<0.05) were found to have higher statistically significant values in acute appendicitis and perforated appendicitis compared to the RDW (p>0.05). However, perforated appendicitis had a higher RDW value compared to acute appendicitis, which can be a predictive factor.

Conclusions: The elevated value of MPV and PDW associated with leukocytosis can be used as supportive evidence for the clinical and radiological diagnosis of acute appendicitis and appendicular perforation. Thus, these values can be used as diagnostic cost-effective inflammatory biomarkers.

背景:急性阑尾炎是世界范围内常见的外科急症。最近对急性阑尾炎血液学炎症标志物的研究显示出不同的结果。目的:本研究的目的是评估术前血小板指数(如平均血小板体积(MPV)、血小板分布宽度(PDW)和红细胞分布宽度(RDW))与急性阑尾炎诊断的关系及其作为阑尾穿孔预测指标的疗效。方法:对190例诊断为阑尾炎并接受阑尾切除术的患者进行前瞻性观察研究,并经组织病理学证实。术前,使用Sysmex XN1000分析仪分析白细胞(WBCs)、血小板计数、MPV、PDW和RDW的血样。结果:190例患者中,169例为急性阑尾炎,21例为穿孔性阑尾炎。患者平均年龄28.04±14.2岁。男女比例为1.5:1。WBC(p0.05)。然而,穿孔性阑尾炎的RDW值高于急性阑尾炎,这可能是一个预测因素。结论:MPV和PDW的升高与白细胞增多有关,可作为急性阑尾炎和阑尾穿孔的临床和放射学诊断的支持性证据。因此,这些值可以用作诊断成本效益高的炎症生物标志物。
{"title":"DIAGNOSIS OF ACUTE APPENDICITIS AND APPENDICULAR PERFORATION: EVALUATION OF PLATELET INDICES AND RED CELL DISTRIBUTION WIDTH AS EMERGING BIOMARKERS.","authors":"Chetan Ag,&nbsp;Vijaya Patil","doi":"10.1590/0102-672020230039e1757","DOIUrl":"https://doi.org/10.1590/0102-672020230039e1757","url":null,"abstract":"<p><strong>Background: </strong>Acute appendicitis is a common surgical emergency worldwide. Recent studies on hematological inflammatory markers concerning acute appendicitis have shown variable results.</p><p><strong>Aims: </strong>The aim of this study was to evaluate pre-operative values of platelet indices such as mean platelet volume (MPV) and platelet distribution width (PDW), and red cell distribution width (RDW) in relation to the diagnosis of acute appendicitis and their efficacy as predictors of appendicular perforation.</p><p><strong>Methods: </strong>A prospective observational study of 190 patients diagnosed with appendicitis and who underwent an appendectomy was undertaken and confirmed histopathologically. Preoperatively, blood samples of white blood cells (WBCs), platelet count, MPV, PDW, and RDW were analyzed using a Sysmex XN1000 analyzer machine.</p><p><strong>Results: </strong>Of 190 patients, 169 had acute appendicitis, and 21 had perforated appendicitis. The mean age of patients was 28.04 ± 14.2 years. The male-to-female ratio was 1.5:1. The WBC (p<0.05), MPV (p<0.05), and PDW (p<0.05) were found to have higher statistically significant values in acute appendicitis and perforated appendicitis compared to the RDW (p>0.05). However, perforated appendicitis had a higher RDW value compared to acute appendicitis, which can be a predictive factor.</p><p><strong>Conclusions: </strong>The elevated value of MPV and PDW associated with leukocytosis can be used as supportive evidence for the clinical and radiological diagnosis of acute appendicitis and appendicular perforation. Thus, these values can be used as diagnostic cost-effective inflammatory biomarkers.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"36 ","pages":"e1757"},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510097/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41162514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ACUTE CHOLECYSTITIS IN HIGH-RISK PATIENTS. SURGICAL, RADIOLOGICAL, OR ENDOSCOPIC TREATMENT? BRAZILIAN COLLEGE OF DIGESTIVE SURGERY POSITION PAPER. 高危患者急性胆囊炎。外科、放射学或内窥镜治疗?巴西消化外科学院立场文件。
Pub Date : 2023-09-15 eCollection Date: 2023-01-01 DOI: 10.1590/0102-672020230031e1749
Júlio Cezar Uili Coelho, Marco Aurélio Raeder da Costa, Marcelo Enne, Orlando Jorge Martins Torres, Wellington Andraus, Antonio Carlos Ligocki Campos

Acute cholecystitis (AC) is an acute inflammatory process of the gallbladder that may be associated with potentially severe complications, such as empyema, gangrene, perforation of the gallbladder, and sepsis. The gold standard treatment for AC is laparoscopic cholecystectomy. However, for a small group of AC patients, the risk of laparoscopic cholecystectomy can be very high, mainly in the elderly with associated severe diseases. In these critically ill patients, percutaneous cholecystostomy or endoscopic ultrasound gallbladder drainage may be a temporary therapeutic option, a bridge to cholecystectomy. The objective of this Brazilian College of Digestive Surgery Position Paper is to present new advances in AC treatment in high-risk surgical patients to help surgeons, endoscopists, and physicians select the best treatment for their patients. The effectiveness, safety, advantages, disadvantages, and outcomes of each procedure are discussed. The main conclusions are: a) AC patients with elevated surgical risk must be preferably treated in tertiary hospitals where surgical, radiological, and endoscopic expertise and resources are available; b) The optimal treatment modality for high-surgical-risk patients should be individualized based on clinical conditions and available expertise; c) Laparoscopic cholecystectomy remains an excellent option of treatment, mainly in hospitals in which percutaneous or endoscopic gallbladder drainage is not available; d) Percutaneous cholecystostomy and endoscopic gallbladder drainage should be performed only in well-equipped hospitals with experienced interventional radiologist and/or endoscopist; e) Cholecystostomy catheter should be removed after resolution of AC. However, in patients who have no clinical condition to undergo cholecystectomy, the catheter may be maintained for a prolonged period or even definitively; f) If the cholecystostomy catheter is maintained for a long period of time several complications may occur, such as bleeding, bile leakage, obstruction, pain at the insertion site, accidental removal of the catheter, and recurrent AC; g) The ideal waiting time between cholecystostomy and cholecystectomy has not yet been established and ranges from immediately after clinical improvement to months. h) Long waiting periods between cholecystostomy and cholecystectomy may be associated with new episodes of acute cholecystitis, multiple hospital readmissions, and increased costs. Finally, when selecting the best treatment option other aspects should also be considered, such as costs, procedures available at the medical center, and the patient's desire. The patient and his family should be fully informed about all treatment options, so they can help making the final decision.

急性胆囊炎(AC)是胆囊的一种急性炎症过程,可能与潜在的严重并发症有关,如脓胸、坏疽、胆囊穿孔和败血症。AC的金标准治疗方法是腹腔镜胆囊切除术。然而,对于一小群AC患者来说,腹腔镜胆囊切除术的风险可能非常高,主要发生在患有相关严重疾病的老年人身上。在这些危重患者中,经皮胆囊造口术或内镜超声胆囊引流术可能是一种临时的治疗选择,是胆囊切除术的桥梁。本巴西消化外科学院立场文件的目的是介绍AC治疗高危外科患者的新进展,以帮助外科医生、内镜医生和医生为患者选择最佳治疗方法。讨论了每种手术的有效性、安全性、优点、缺点和结果。主要结论是:a)手术风险较高的AC患者必须最好在三级医院接受治疗,那里有外科、放射学和内窥镜的专业知识和资源;b) 高手术风险患者的最佳治疗方式应根据临床条件和现有专业知识进行个性化;c) 腹腔镜胆囊切除术仍然是一种很好的治疗选择,主要是在无法进行经皮或内镜胆囊引流的医院;d) 经皮胆囊造口术和内镜胆囊引流术只能在设备齐全、有经验的介入放射科医生和/或内镜医生的医院进行;e) 胆囊造口术导管应在AC消退后取出。然而,对于没有临床条件进行胆囊切除术的患者,导管可能会长期使用,甚至最终使用;f) 如果胆囊造口术导管长期使用,可能会出现多种并发症,如出血、胆汁渗漏、梗阻、插入部位疼痛、意外取出导管和复发性AC;g) 胆囊造口术和胆囊切除术之间的理想等待时间尚未确定,从临床好转后立即到几个月不等。h) 胆囊造口术和胆囊切除术之间的漫长等待期可能与新的急性胆囊炎发作、多次住院和费用增加有关。最后,在选择最佳治疗方案时,还应考虑其他方面,如费用、医疗中心的可用程序和患者的意愿。患者及其家人应充分了解所有治疗方案,以便他们能够帮助做出最终决定。
{"title":"ACUTE CHOLECYSTITIS IN HIGH-RISK PATIENTS. SURGICAL, RADIOLOGICAL, OR ENDOSCOPIC TREATMENT? BRAZILIAN COLLEGE OF DIGESTIVE SURGERY POSITION PAPER.","authors":"Júlio Cezar Uili Coelho,&nbsp;Marco Aurélio Raeder da Costa,&nbsp;Marcelo Enne,&nbsp;Orlando Jorge Martins Torres,&nbsp;Wellington Andraus,&nbsp;Antonio Carlos Ligocki Campos","doi":"10.1590/0102-672020230031e1749","DOIUrl":"https://doi.org/10.1590/0102-672020230031e1749","url":null,"abstract":"<p><p>Acute cholecystitis (AC) is an acute inflammatory process of the gallbladder that may be associated with potentially severe complications, such as empyema, gangrene, perforation of the gallbladder, and sepsis. The gold standard treatment for AC is laparoscopic cholecystectomy. However, for a small group of AC patients, the risk of laparoscopic cholecystectomy can be very high, mainly in the elderly with associated severe diseases. In these critically ill patients, percutaneous cholecystostomy or endoscopic ultrasound gallbladder drainage may be a temporary therapeutic option, a bridge to cholecystectomy. The objective of this Brazilian College of Digestive Surgery Position Paper is to present new advances in AC treatment in high-risk surgical patients to help surgeons, endoscopists, and physicians select the best treatment for their patients. The effectiveness, safety, advantages, disadvantages, and outcomes of each procedure are discussed. The main conclusions are: a) AC patients with elevated surgical risk must be preferably treated in tertiary hospitals where surgical, radiological, and endoscopic expertise and resources are available; b) The optimal treatment modality for high-surgical-risk patients should be individualized based on clinical conditions and available expertise; c) Laparoscopic cholecystectomy remains an excellent option of treatment, mainly in hospitals in which percutaneous or endoscopic gallbladder drainage is not available; d) Percutaneous cholecystostomy and endoscopic gallbladder drainage should be performed only in well-equipped hospitals with experienced interventional radiologist and/or endoscopist; e) Cholecystostomy catheter should be removed after resolution of AC. However, in patients who have no clinical condition to undergo cholecystectomy, the catheter may be maintained for a prolonged period or even definitively; f) If the cholecystostomy catheter is maintained for a long period of time several complications may occur, such as bleeding, bile leakage, obstruction, pain at the insertion site, accidental removal of the catheter, and recurrent AC; g) The ideal waiting time between cholecystostomy and cholecystectomy has not yet been established and ranges from immediately after clinical improvement to months. h) Long waiting periods between cholecystostomy and cholecystectomy may be associated with new episodes of acute cholecystitis, multiple hospital readmissions, and increased costs. Finally, when selecting the best treatment option other aspects should also be considered, such as costs, procedures available at the medical center, and the patient's desire. The patient and his family should be fully informed about all treatment options, so they can help making the final decision.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"36 ","pages":"e1749"},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510100/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41166659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
PANCREATODUODENECTOMY DUE TO LIPOMATOUS PSEUDOHYPERTROPHY OF THE PANCREAS. 胰腺假性肥大引起的胰腺十二指肠切除术。
Pub Date : 2023-09-15 eCollection Date: 2023-01-01 DOI: 10.1590/0102-672020230036e1754
Orlando Jorge Martins Torres, Rodrigo Rodrigues Vasques, Cláudio Matias Barros Júnior, Galvani Ascar Sauaia Filho, Benedito Dario Murad Mouchrek, Marcelo Lima Rocha, Rennan Abud Pinheiro Santos, Milena Vasconcelos Falcão, José Maria Assunção Moraes Júnior

Background: Lipomatous pseudohypertrophy of the pancreas, pancreatic lipomatosis, pancreatic steatosis, non-alcoholic fatty pancreatic disease, or fatty pancreas is an extremely rare disease, characterized by the organ enlargement and a localized or diffuse replacement of pancreatic acinar cells by mature adipose tissue, preserving the pancreatic ductal system and islets of Langerhans.

Aims: To report a rare case of lipomatous pseudohypertrophy of the pancreas in a symptomatic patient and the surgical treatment employed.

Methods: A 24-year-old male patient with weight loss (10 kilograms in 8 months), hyperglycemia, severe and recurrent acute abdominal pain, epigastric discomfort associated with nausea, vomiting, and jaundice for 40 days. Magnetic resonance imaging was performed, revealing an irregular lipomatous pseudohypertrophy of the pancreas, measuring 6.0 × 5.6 cm in the head, uncinate process, and part of the body of the pancreas. The pancreatic duct dilation was diffuse and irregular, associated with atrophy of the remnant parenchyma, particularly in the tail of the pancreas. The patient underwent pancreatoduodenectomy without total mesopancreas excision followed by pancreatojejunostomy.

Results: The postoperative course was uneventful, the length of stay in the ICU was two days, and the patient was discharged on the seventh postoperative day.

Conclusions: The disease treatment depends on the signs and symptoms at presentation and a pancreatoduodenectomy is indicated in patients with severe and recurrent abdominal pain.

背景:胰腺脂肪瘤性假肥大、胰腺脂肪瘤病、胰腺脂肪变性、非酒精性脂肪性胰腺疾病或脂肪胰腺是一种极为罕见的疾病,其特征是器官增大,胰腺腺泡细胞被成熟脂肪组织局部或弥漫性替代,保留胰腺导管系统和胰岛。目的:报告一例罕见的有症状的胰腺脂肪瘤性假性肥大患者及其手术治疗。方法:一名24岁男性患者,体重减轻(8个月10公斤),高血糖,严重和复发性急性腹痛,上腹部不适伴恶心、呕吐和黄疸,持续40天。进行了磁共振成像,显示胰腺的不规则脂肪瘤假肥大,在胰腺的头部、钩突和部分身体测量为6.0×5.6厘米。胰管扩张呈弥漫性和不规则性,与残余薄壁组织萎缩有关,尤其是胰腺尾部。患者接受了胰十二指肠切除术,未进行全中胰切除,随后进行了胰肠造口术。结果:术后病程平稳,ICU住院时间为2天,患者于术后第7天出院。结论:疾病的治疗取决于出现时的体征和症状,对于严重和复发性腹痛的患者,建议进行胰十二指肠切除术。
{"title":"PANCREATODUODENECTOMY DUE TO LIPOMATOUS PSEUDOHYPERTROPHY OF THE PANCREAS.","authors":"Orlando Jorge Martins Torres,&nbsp;Rodrigo Rodrigues Vasques,&nbsp;Cláudio Matias Barros Júnior,&nbsp;Galvani Ascar Sauaia Filho,&nbsp;Benedito Dario Murad Mouchrek,&nbsp;Marcelo Lima Rocha,&nbsp;Rennan Abud Pinheiro Santos,&nbsp;Milena Vasconcelos Falcão,&nbsp;José Maria Assunção Moraes Júnior","doi":"10.1590/0102-672020230036e1754","DOIUrl":"https://doi.org/10.1590/0102-672020230036e1754","url":null,"abstract":"<p><strong>Background: </strong>Lipomatous pseudohypertrophy of the pancreas, pancreatic lipomatosis, pancreatic steatosis, non-alcoholic fatty pancreatic disease, or fatty pancreas is an extremely rare disease, characterized by the organ enlargement and a localized or diffuse replacement of pancreatic acinar cells by mature adipose tissue, preserving the pancreatic ductal system and islets of Langerhans.</p><p><strong>Aims: </strong>To report a rare case of lipomatous pseudohypertrophy of the pancreas in a symptomatic patient and the surgical treatment employed.</p><p><strong>Methods: </strong>A 24-year-old male patient with weight loss (10 kilograms in 8 months), hyperglycemia, severe and recurrent acute abdominal pain, epigastric discomfort associated with nausea, vomiting, and jaundice for 40 days. Magnetic resonance imaging was performed, revealing an irregular lipomatous pseudohypertrophy of the pancreas, measuring 6.0 × 5.6 cm in the head, uncinate process, and part of the body of the pancreas. The pancreatic duct dilation was diffuse and irregular, associated with atrophy of the remnant parenchyma, particularly in the tail of the pancreas. The patient underwent pancreatoduodenectomy without total mesopancreas excision followed by pancreatojejunostomy.</p><p><strong>Results: </strong>The postoperative course was uneventful, the length of stay in the ICU was two days, and the patient was discharged on the seventh postoperative day.</p><p><strong>Conclusions: </strong>The disease treatment depends on the signs and symptoms at presentation and a pancreatoduodenectomy is indicated in patients with severe and recurrent abdominal pain.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"36 ","pages":"e1754"},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510371/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41166870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
OLIGOMETASTASIS IN GASTRIC CANCER TREATMENT: IS THERE A PLACE FOR THE SURGEON? 胃癌治疗中的少转移:有外科医生的位置吗?
Pub Date : 2023-09-15 eCollection Date: 2023-01-01 DOI: 10.1590/0102-672020230034e1752
Paulo Pimentel de Assumpção, Jéssica Manoelli Costa da Silva, Danielle Queiroz Calcagno, Williams Fernandes Barra, Geraldo Ishak, Paulo Kassab

Metastatic gastric cancer traditionally hinders surgical treatment options, confining them to palliative procedures. The presence of metastases in these tumors is classified as M1, irrespective of their characteristics, quantity, or location. However, oligometastatic disease emerged as an intermediate state between localized and widely disseminated cancer. It exhibits diverse patterns based on metastatic disease extent, type, and location. Adequately addressing this distinctive metastatic state necessitates tailored strategies that surpass the realm of palliative care. Differentprimary tumor types present discernible scenarios of oligometastatic disease, including preferred sites of occurrence and chronological progression. Due to the novelty of this theme and the heterogeneity of the disease, uncertainties still exist, and the ability to provide confident guidelines is challenging. Currently, there are no effective predictors to determine the response and provide clear indications for surgical interventions and systemic treatments in oligometastatic disease. Treatment decisions are commonly based on apparent disease control by systemic therapies, with a short observation period and imaging assessments. Nonetheless, the inherent risk of misinterpretation remains a constant concern. The emergence of novel technologies and therapeutic modalities, such as immunotherapy, cellular therapy, and adoptive therapies, holds the potential to reshape the landscape of surgical treatment for the oligometastatic disease in gastric cancer, expanding the surgeon's role in this multidisciplinary approach. Prospective tools for patient selection in oligometastatic gastric cancer are being explored. Using non-invasive, cost-effective, widely available imaging techniques that provide real-time information may revolutionize medical practice, ensuring precision medicine accessibility, even in resource-constrained small healthcare facilities. Incorporating molecular classifications, liquid biopsies, and radiomic analysis in a complementary protocol will augment patient selection precision for surgical intervention in oligometastasis. Hopefully, these advancements will render surgeries unnecessary in many cases by providing highly effective alternative treatments.

转移性癌症传统上阻碍了手术治疗的选择,将其限制在姑息治疗。这些肿瘤中转移的存在被归类为M1,而与它们的特征、数量或位置无关。然而,少转移性疾病作为癌症局部和广泛扩散之间的中间状态出现。根据转移性疾病的程度、类型和位置,它表现出不同的模式。充分解决这种独特的转移状态需要量身定制的策略,超越姑息治疗的领域。不同的原发性肿瘤类型表现出明显的少转移性疾病,包括首选的发生部位和按时间顺序发展。由于这个主题的新颖性和疾病的异质性,不确定性仍然存在,提供自信指南的能力具有挑战性。目前,还没有有效的预测因素来确定反应,并为少转移性疾病的手术干预和系统治疗提供明确的指征。治疗决策通常基于系统治疗的明显疾病控制,观察期短,影像学评估。尽管如此,误解的固有风险仍然是一个持续关注的问题。新技术和治疗模式的出现,如免疫疗法、细胞疗法和过继疗法,有可能重塑癌症少转移疾病的外科治疗格局,扩大外科医生在这一多学科方法中的作用。正在探索用于少转移性癌症患者选择的前瞻性工具。使用提供实时信息的非侵入性、成本效益高、广泛可用的成像技术可能会彻底改变医疗实践,确保精确的医疗可及性,即使在资源有限的小型医疗机构中也是如此。在补充方案中结合分子分类、液体活检和放射组学分析将提高患者对少转移手术干预的选择精度。希望这些进步将通过提供高效的替代治疗,在许多情况下使手术变得不必要。
{"title":"OLIGOMETASTASIS IN GASTRIC CANCER TREATMENT: IS THERE A PLACE FOR THE SURGEON?","authors":"Paulo Pimentel de Assumpção,&nbsp;Jéssica Manoelli Costa da Silva,&nbsp;Danielle Queiroz Calcagno,&nbsp;Williams Fernandes Barra,&nbsp;Geraldo Ishak,&nbsp;Paulo Kassab","doi":"10.1590/0102-672020230034e1752","DOIUrl":"https://doi.org/10.1590/0102-672020230034e1752","url":null,"abstract":"<p><p>Metastatic gastric cancer traditionally hinders surgical treatment options, confining them to palliative procedures. The presence of metastases in these tumors is classified as M1, irrespective of their characteristics, quantity, or location. However, oligometastatic disease emerged as an intermediate state between localized and widely disseminated cancer. It exhibits diverse patterns based on metastatic disease extent, type, and location. Adequately addressing this distinctive metastatic state necessitates tailored strategies that surpass the realm of palliative care. Differentprimary tumor types present discernible scenarios of oligometastatic disease, including preferred sites of occurrence and chronological progression. Due to the novelty of this theme and the heterogeneity of the disease, uncertainties still exist, and the ability to provide confident guidelines is challenging. Currently, there are no effective predictors to determine the response and provide clear indications for surgical interventions and systemic treatments in oligometastatic disease. Treatment decisions are commonly based on apparent disease control by systemic therapies, with a short observation period and imaging assessments. Nonetheless, the inherent risk of misinterpretation remains a constant concern. The emergence of novel technologies and therapeutic modalities, such as immunotherapy, cellular therapy, and adoptive therapies, holds the potential to reshape the landscape of surgical treatment for the oligometastatic disease in gastric cancer, expanding the surgeon's role in this multidisciplinary approach. Prospective tools for patient selection in oligometastatic gastric cancer are being explored. Using non-invasive, cost-effective, widely available imaging techniques that provide real-time information may revolutionize medical practice, ensuring precision medicine accessibility, even in resource-constrained small healthcare facilities. Incorporating molecular classifications, liquid biopsies, and radiomic analysis in a complementary protocol will augment patient selection precision for surgical intervention in oligometastasis. Hopefully, these advancements will render surgeries unnecessary in many cases by providing highly effective alternative treatments.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"36 ","pages":"e1752"},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510098/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41169942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ROBOTIC VERSUS LAPAROSCOPIC ROUX-EN-Y-GASTRIC BYPASS: A RETROSPECTIVE STUDY IN A SINGLE CENTER. 机器人与腹腔镜ROUX-EN-Y-胃旁路术:一项单一中心的回顾性研究。
Pub Date : 2023-09-15 eCollection Date: 2023-01-01 DOI: 10.1590/0102-672020230038e1756
Fernando de Barros, Ana Beatriz Monteiro Fonseca, Amanda Sebestjen Balogh Kiss, Camilla Ferreira Braga, Filipe Roza DA-Silva, Yumi Honda Regonati

Background: Bariatric surgery is the best treatment option for patients with obesity. As a result of the advancement of technology, the robotic gastric bypass presents promising results, despite its still high costs.

Aims: The aim of this study was to compare patients submitted to a robotic versus a laparoscopic gastric bypass at a single center by a single surgeon.

Methods: This retrospective study collected data from the medical records of 221 patients (121 laparoscopic procedures versus 100 with daVinci platform). The variables analyzed were sex, age, body mass index, comorbidities, surgical time, length of stay, and complications.

Results: The mean surgical time for patients in the robotic group was shorter (102.41±39.44 min versus 113.86±39.03 min, p=0.018). The length of hospital stay in robotic patients was shorter (34.12±20.59 h versus 34.93±11.74 h, p=0.007). There were no serious complications.

Conclusions: The group submitted to the robotic method had a shorter surgical time and a shorter hospital stay. No difference was found regarding strictures, bleeding, or leakage.

背景:减肥手术是治疗肥胖患者的最佳选择。由于技术的进步,尽管成本仍然很高,但机器人胃旁路术仍取得了有希望的结果。目的:本研究的目的是比较由一名外科医生在一个中心接受机器人胃旁路手术和腹腔镜胃旁路手术的患者。方法:这项回顾性研究收集了221名患者的医疗记录数据(121例腹腔镜手术,100例使用达芬奇平台)。分析的变量包括性别、年龄、体重指数、合并症、手术时间、住院时间和并发症。结果:机器人组患者的平均手术时间更短(102.41±39.44分钟对113.86±39.03分钟,p=0.018)。机器人患者的住院时间更短(34.12±20.59小时对34.93±11.74小时,p=0.007)。没有严重并发症。结论:采用机器人方法的组手术时间更短,住院时间更短。在狭窄、出血或渗漏方面没有发现差异。
{"title":"ROBOTIC VERSUS LAPAROSCOPIC ROUX-EN-Y-GASTRIC BYPASS: A RETROSPECTIVE STUDY IN A SINGLE CENTER.","authors":"Fernando de Barros,&nbsp;Ana Beatriz Monteiro Fonseca,&nbsp;Amanda Sebestjen Balogh Kiss,&nbsp;Camilla Ferreira Braga,&nbsp;Filipe Roza DA-Silva,&nbsp;Yumi Honda Regonati","doi":"10.1590/0102-672020230038e1756","DOIUrl":"https://doi.org/10.1590/0102-672020230038e1756","url":null,"abstract":"<p><strong>Background: </strong>Bariatric surgery is the best treatment option for patients with obesity. As a result of the advancement of technology, the robotic gastric bypass presents promising results, despite its still high costs.</p><p><strong>Aims: </strong>The aim of this study was to compare patients submitted to a robotic versus a laparoscopic gastric bypass at a single center by a single surgeon.</p><p><strong>Methods: </strong>This retrospective study collected data from the medical records of 221 patients (121 laparoscopic procedures versus 100 with daVinci platform). The variables analyzed were sex, age, body mass index, comorbidities, surgical time, length of stay, and complications.</p><p><strong>Results: </strong>The mean surgical time for patients in the robotic group was shorter (102.41±39.44 min versus 113.86±39.03 min, p=0.018). The length of hospital stay in robotic patients was shorter (34.12±20.59 h versus 34.93±11.74 h, p=0.007). There were no serious complications.</p><p><strong>Conclusions: </strong>The group submitted to the robotic method had a shorter surgical time and a shorter hospital stay. No difference was found regarding strictures, bleeding, or leakage.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"36 ","pages":"e1756"},"PeriodicalIF":0.0,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510099/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41163966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1